Refining Treatment Strategies for Iron Deficient Athletes

  • PDF / 947,746 Bytes
  • 13 Pages / 595.276 x 790.866 pts Page_size
  • 111 Downloads / 245 Views

DOWNLOAD

REPORT


REVIEW ARTICLE

Refining Treatment Strategies for Iron Deficient Athletes Rachel McCormick1,2   · Marc Sim3,4 · Brian Dawson1 · Peter Peeling1,2

© Springer Nature Switzerland AG 2020

Abstract Iron deficiency (ID) is a prevailing nutritional concern amongst the athletic population due to the increased iron demands of this group. Athletes’ ability to replenish taxed iron stores is challenging due to the low bioavailability of dietary sources, and the interaction between exercise and hepcidin, the primary iron-regulatory hormone. To date, copious research has explored the link between exercise and iron regulation, with a more recent focus on optimising iron treatment applications. Currently, oral iron supplementation is typically the first avenue of iron replacement therapy beyond nutritional intervention, for treatment of ID athletes. However, many athletes encounter associated gastrointestinal side-effects which can deter them from fulfilling a full-term oral iron treatment plan, generally resulting in sub-optimal treatment efficacy. Consequently, various strategies (e.g. dosage, composition, timing) of oral iron supplementation have been investigated with the goal of increasing fractional iron absorption, reducing gastric irritation, and ultimately improving the efficacy of oral iron therapy. This review explores the various treatment strategies pertinent to athletes and concludes a contemporary strategy of oral iron therapy entailing morning supplementation, ideally within the 30 min following morning exercise, and in athletes experiencing gut sensitivity, consumed on alternate days or at lower doses.

1 Introduction Iron deficiency (ID) is regarded as a spectrum that progresses as a result of negative iron balance. Earlier stages of ID are collectively referred to as iron deficiency nonanaemia (IDNA), characterised by the conservation of healthy haemoglobin in the presence of inadequate iron indices (serum ferritin; sFer range